News

August 24, 2018August 24, 2018

Actemra, Kineret Have Similar One-Year Efficacy in sJIA Patients, Study Finds

News

Treatment of systemic juvenile idiopathic arthritis (sJIA) with either the approved therapy Actemra (tocilizumab) or Kineret (anakinra, not yet approved for sJIA) led to similar effectiveness after one year, according to a new ... Read more

August 20, 2018August 20, 2018

Early Decrease in Inflammatory Molecule IL-6 is Predictor of Clinical Remission, Study Shows

News

An early reduction in levels of the inflammatory molecule IL-6 is significantly associated with clinical remission at two years after diagnosis in patients with systemic juvenile idiopathic arthritis, a study ... Read more

August 6, 2018August 6, 2018

Naproxen-based Combo May Help Reduce Risk of Gastric Ulcers in JIA Teens, Phase 4 Trial Shows

News

Results from a six-month, Phase 4 trial support a combination therapy of the anti-inflammatory naproxen together with an immediate-release form of esomeprazole to reduce the risk of gastric ulcers in ... Read more

July 30, 2018July 30, 2018

Orofacial Pain Fairly Common – and Disabling – in Children, Study Reports

News

Orofacial pain — continuous discomfort in the mouth, jaws, and face — can be fairly common and persistent in children with juvenile idiopathic arthritis (JIA), and sufficiently limiting to negatively ... Read more

July 23, 2018July 23, 2018

Low Number of Regulatory B-cells May Help Fuel Juvenile Idiopathic Arthritis, Study Suggests

News

Low numbers of a group of immune cells — called regulatory B-cells — that help to control inflammation may underlie the development of juvenile idiopathic arthritis (JIA), early research suggests. ... Read more

July 16, 2018July 16, 2018

Kineret Now Available in UK for Systemic-onset JIA and Still’s Disease

News

Kineret (anakinra), developed by Sobi, is now available as a treatment option in the United Kingdom for patients with systemic-onset juvenile idiopathic arthritis (SJIA) and adult-onset Still’s disease (AOSD). This ... Read more

July 9, 2018July 9, 2018

Enrollment Complete for Phase 4 Trial Assessing H.P. Acthar Gel in Rheumatoid Arthritis

News

The phase 4 study evaluating H.P. Acthar Gel in patients with rheumatoid arthritis exceeded its enrollment goal, Mallinckrodt Pharmaceuticals announced. The ongoing study enrolled more than 230 adult patients over ... Read more

June 29, 2018June 29, 2018

JIA Children with Treatment Can Attain Quality of Life Comparable to Healthy Peers, Study Says

News

Treating children with juvenile idiopathic arthritis (JIA) helps them to achieve a quality of life comparable to that of any healthy child, and that is a realistic clinical goal, a German study ... Read more

June 25, 2018June 25, 2018

60% of JIA Patients Who Stop Taking Enbrel Experience Relapses, Study Finds

News

A significant number of patients with juvenile idiopathic arthritis (JIA) who stop taking Enbrel (etanercept) experience relapses. This happens more frequently in males and in patients with antinuclear antibodies and higher ... Read more

June 22, 2018June 22, 2018

New Study to Determine if Arthritis Patients May Be Able to Successfully Reduce Medication

News

A new study by Canadian researchers will explore the possibility of reducing medication for arthritis patients whose disease has already been under control for a certain period of time. Arthritis ... Read more